Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer: a secondary analysis of the BOLERO‑2 clinical trial - Chandarlapaty, S; Chen, D; He, W (JAMA Oncol, 2016)
et al.